Fig. 4: NHP survival and clinical signs. | npj Vaccines

Fig. 4: NHP survival and clinical signs.

From: Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease

Fig. 4

Clinical measurements of LASV disease throughout the NHP challenge study. a Kaplan-Meyer survival curves. Significance between groups was determined using the log-rank Mantel-Cox test (***P = 0.0004). b Clinical scores for individual NHPs. c Changes in weight over time for individual NHPs. d Group average changes in body temperature over time.

Back to article page